Esmerilda G Delicado Selected Research

purinoceptor P2Y4

1/2020

Update of P2Y receptor pharmacology: IUPHAR Review 27.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Esmerilda G Delicado Research Topics

Disease

2	Inflammation (Inflammations) 01/2017 - 04/2013
1	Rupture 01/2021
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2020
1	Brain Diseases (Brain Disorder) 04/2019
1	Pain (Aches) 01/2017
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2016
1	Brain Injuries (Brain Injury) 01/2016
1	Neuroblastoma 12/2012

Drug/Important Bio-Agent (IBA)

2	Dinoprostone (PGE2)FDA Link 01/2017 - 04/2013
2	NucleotidesIBA 01/2016 - 04/2013
1	Uridine Triphosphate (UTP)IBA 01/2021
1	Purinergic P2Y1 ReceptorsIBA 01/2020
1	purinoceptor P2Y4IBA 01/2020
1	Therapeutic UsesIBA 04/2019
1	GTP-Binding Proteins (G-Protein)IBA 01/2017
1	CholesterolIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	LipidsIBA 01/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017
1	pyrimidineIBA 04/2013
1	ChromatinIBA 12/2012
1	Purinergic P2X7 ReceptorsIBA 12/2012

Therapy/Procedure

1	Transplantation 01/2016